Saturday, March 12, 2022

Assessing Allergic Reactions to COVID-19 mRNA Vaccine, and More

HM-New-Saturday-ep145-Revamp-12Mar22
Hi Renukaprasad A R,
Docplexus News brings you the latest happenings in the field of medical science.
Top Stories of the Day:
Assessing Allergic Reactions to COVID-19 mRNA Vaccine
The NIH has launched a clinical trial to study the spectrum of allergic reactions of mRNA-based COVID-19 vaccines after the first dose of vaccination in participants between 16 to 69 years of age.
Launch of Next Generation Closed-loop Insulin Pump System
A renowned pharma giant has launched the next-generation closed-loop insulin pump system that enables the personalization of glucose levels with adjustable targets.
Mechanism of Action of Siponimod
Investigators from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center have identified how Siponimod, a drug for multiple sclerosis, can act as a targeted drug, interacting with its target receptor S1P1, an additional receptor S1P5, but not with any other unwanted receptors.
Liver Injury-induced Bone Loss
According to a study with the mice model for hepatic osteodystrophy disease, an imbalance of the liver-bone axis accelerates the progression of the disease caused by chronic liver injury.
This Week's Trending News JUST for You. Listen to 'Docplexus Health Minute' from Monday to Friday and 'Health Minute Highlights' on Saturday & Sunday!
India's Largest Online Community Of Doctors
Pune - 411045, India
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*